WeVote
Log In

Bill

Bill

S 7582

Requires recommendation of blood lead level screenings when a health care provider finds high lead levels in blood of a child

2025 Regular Session Introduced by Cordell Cleare

Requires clinicians to recommend follow-up blood lead level screening when a child's test shows high lead levels, boosting early detection and access to care.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 7582

Summary: S 7582 – Requires recommendation of blood lead level screenings when a health care provider finds high lead levels in blood of a child

Overview

S 7582 is a Senate bill introduced on April 23, 2025, and referred to the Health committee. Sponsored by Cordell Cleare (primary), the measure seeks to ensure that when a health care provider detects elevated blood lead levels (BLL) in a child, they must recommend blood lead level screenings. The bill has several related and companion measures in the Assembly, indicating broader interest in lead exposure screening and follow-up.

  • Bill number: S 7582
  • Title: Requires recommendation of blood lead level screenings when a health care provider finds high lead levels in blood of a child
  • Introduced: April 23, 2025
  • Status: Referred to Health
  • Primary sponsor: Cordell Cleare
  • Related/companion bills: A 7224 (companion), A 11198, A 669, A 5748, S 8186 (prior sessions)

What the bill would do

  • Core requirement: Mandates that health care providers who identify high lead levels in a child’s blood must recommend additional blood lead level screening.
  • Scope (inferred): The provision targets pediatric patients who undergo testing and receive a result indicating elevated lead exposure, requiring clinicians to advise guardians about further screening options.
  • Documentation and follow-up (likely): Although text is not provided, such measures typically require documentation of the screening recommendation in the patient’s medical record and may include referrals or information on access to screening services.

Key provisions and changes (inference based on the title)

  • Clinician obligation: A formal requirement for providers to communicate and recommend follow-up BLL screening whenever elevated lead is detected.
  • Follow-up pathway: The bill would likely encourage or mandate a pathway for follow-up testing, which could include scheduling, referrals to public health programs, or guidance on reducing lead exposure.
  • Public health integration: By ensuring more systematic follow-up, the measure aims to improve early identification of ongoing lead exposure and support interventions to mitigate health risks.

Who would be affected

  • Children with elevated blood lead levels and their families, who would receive recommended follow-up screening.
  • Healthcare providers (pediatricians, family medicine, clinics) who perform BLL testing and would implement the recommendation requirement.
  • Healthcare facilities and clinical administrators responsible for documentation and referrals.
  • Public health entities that may coordinate follow-up screening and resources.

Procedural and timeline aspects

  • Status: Referred to Health (as of the latest available update).
  • Legislative actions: Both the initial and identical entry on 2025-04-23 note the referral to the Health committee.
  • Related activity: Companion bill A 7224 exists (and others in prior sessions), suggesting cross-chamber consideration and potential alignment with Assembly measures.

Potential impacts and considerations

  • Public health impact: If implemented, could improve early detection of ongoing lead exposure and enable timely interventions, potentially reducing lead-related health risks in children.
  • Implementation questions: Definitions of “high lead levels,” patient age range, specifics of the required recommendation (verbal vs. written, timing, and cadence of follow-up), and any penalties or enforcement mechanisms would be determined in the bill’s final text.
  • Accessibility: Success depends on access to follow-up screening services and resources for families.

Next steps

  • Monitor committee actions in Health for any hearings, amendments, or passage.
  • Review the full bill text and any fiscal notes when available to assess cost implications and administrative requirements.
  • Consider connection to related measures (companion and prior-session bills) for a fuller understanding of legislative intent and potential consensus.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.